We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 118
Most popular |Most recent

Herbert Smith Freehills’ Brexit Legal Guide updated - comparison of IP and pharma provisions in the draft Withdrawal Agreement versus the No Deal provisions promised by the UK Government

United Kingdom, European Union - January 14 2019 See the updated IP section of the Herbert Smith Freehills Brexit Legal Guide which reviews the IP and pharma elements of the draft Withdrawal...

Changes to the UK trade mark regime: Trade Marks Regulations 2018 - coming into force on 14 January 2019

United Kingdom - January 9 2019 The new EU Trade Mark Directive (20152436), designed, in part, to make trade mark law across the EU fit for the digital age, will be implemented into...

Laura Deacon, Joel Smith.

Intellectual property and Brexit (including pharmaceutical sector provisions)

United Kingdom, European Union - December 31 2018 IP rights which are designated as applying across the EU (EU trade marks, Community plant variety rights, Community registered designs and Community...

Joel Smith.

Preparations for the UPC continue despite an “unpredictable environment”

European Union, Germany - December 20 2018 The UPC Preparatory Committee has issued a “Status of the Unified Patent Court Project” statement and review of 2018, confirming that there are now 16...

Patent and Pharma Update

United Kingdom, European Union - December 11 2018 The Supreme Court's decision in Warner-Lambert v Actavis and Mylan is disappointing news for patentees who may have made significant investment in R&D...

Jonathan Turnbull, Krishna Kakkaiyadi.